Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from FDA

Baby food in California to be tested for dangerous metals under new law

From 1 January 2024, baby food makers will be required to post results on their websites.

The Independent UK

Alnylam Is Now 'One Of The Most Binary' Stories In Biotech. Why The FDA Rejected Its Heart Drug.

Alnylam stock skidded Monday after the FDA rejected its drug, Onpattro, as a treatment for patients with a heart disease.

Investors Business Daily

Mirati Therapeutics Snags $5.8 Billion Takeover Deal, But Shares Fall On Lowball Price

Bristol Myers Squibb offered to buy Mirati Therapeutics for up to $5.8 billion, but MRTX stock tumbled on the lowball price.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Rare Ozempic side effects emerging

Though side effects from Ozempic are rare, as usage rises some side effects are becoming more apparent

Salon

Arkansas jail inmates settle lawsuit with doctor who prescribed them ivermectin for COVID-19

Five former inmates at an Arkansas county jail have settled their lawsuit against a doctor who they say gave them ivermectin without their consent to treat COVID-19

The Independent UK

T2 Biosystems (TTOO) vs. IDEXX Laboratories (IDXX): Which Medical Stock Is Poised for More October Gains?

With an aging population worldwide, the rising prevalence of chronic diseases, and numerous technological advancements, the medical device sector stands primed for considerable growth and expansion. The industry tailwinds should benefit medical device stocks T2 Biosystems (TTOO) and IDEXX Laboratories (IDXX). However, which stock is poised for better gains this…

StockNews.com

Novavax Surges After FDA Signs Off On Its Updated Covid Shot, Joining Pfizer, Moderna

The Food and Drug Administration signed off on Novavax's updated Covid booster late Tuesday, and NVAX stock surged just before the close.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Children as young as seven in hospital after eating cannabis sweets in Jamaica

More than 60 primary schoolchildren have been taken to hospital after eating cannabis-laced sweets in Jamaica.

Evening Standard

We know how to regulate new drugs and medical devices–but we’re about to let health care AI run amok

Doctors need to get into the AI oversight game–before it's too late.

Fortune

Supreme Court to consider abortion pills, guns, social media in its new term

In one form or another, all those questions are back on the table this term — mainly to take a second look at appeals from the Fifth Circuit Court of Appeals, which covers Texas and parts the South.

WEKU

US regulator's approval a 'game-changer' for Cyclopharm

Sydney-based Cyclopharm is preparing to send hundreds of its generators to the US for use in diagnosing pulmonary embolisms after receiving regulatory approval.

AAP

How psychedelic retreats can help heal

Psychedelic retreats are becoming more popular as people wait for FDA approval. But do they work?

Salon

Kosher Prices Soar, Jewish Families Get Creative For High Holidays

Rising costs prompt budget creativity and alternative shopping strategies for Jewish families preparing for holidays.

Zenger

FDA wants to regulate thousands of lab tests that have long skirted oversight

The Food and Drug Administration says it plans to begin regulating laboratory-based medical tests

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

NOT REAL NEWS: A look at what didn't happen this week

Social media users shared a range of false claims this week

Reason

Sales Data Indicate That Restrictions on Flavored Vaping Products Encourage Smoking

A study found a "high rate of substitution" between vapes and cigarettes, suggesting that policies aimed at preventing underage use are undermining public health.

Barchart

An AI-Powered Healthcare Stock to Buy on the Dip

GE Healthcare stock has pulled back from its 2023 highs amid a broader swoon in stocks, but analysts love the outlook for this AI-powered imaging specialist. Is GEHC stock a good buy now?

Investors Business Daily

Karuna Takes A Big Step In Schizophrenia Treatment. But Shares Yo-Yo.

Karuna Therapeutics asked the Food and Drug Administration to approve its schizophrenia treatment on Thursday, and KRTX stock rose.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Crispr Therapeutics, And CRISPR Gene-Editing, Face Their Make-Or-Break Moment

Crispr is facing its make-or-break moment and, experts say, a pivotal decision in December could spark more than just beleaguered CRSP stock.

Chicago Sun-Times

Common children’s antibiotic amoxicillin still in short supply for the second year

While pharmacies say they can still fill most prescriptions for amoxicillin, the most-prescribed drug in the country, the shortage could worsen when the viral season hits this winter, experts say.

The Independent UK

California Gov. Gavin Newsom signs law to protect doctors who mail abortion pills to other states

California Gov. Gavin Newsom has signed a law protecting doctors and pharmacists who mail abortion pills to patients in other states

The Independent UK

FDA advisers vote against experimental ALS treatment pushed by patients

Federal health advisers have voted overwhelmingly against recommending approval of an experimental treatment for Lou Gehrig's disease, the fatal muscle-wasting disease

The Independent UK

Do Covid tests work after they expire? What to know as case counts rise across the US

Some, but not all, at-home tests have been given extended expiration dates by the FDA

The Independent UK

What to know about the new Covid booster shots

Updated vaccines will be especially important to high-risk people, such as pregnant women and the elderly

Salon

The first OTC birth control is coming

An OTC birth control pill will help ensure more people can access the contraception they need without barriers

1 … 75 76 77 78

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.